Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: GARY P GROBBEL who wrote (17997)	2/17/2004 10:55:19 AM
From: GARY P GROBBEL	Respond to of 120415

NGNM .70 up .20...this is a sweet little genomics company that has been moving up of late...no news of real consequence but sometimes you don't want news...: (COMTEX) B: NeoGenomics, Inc. Announces New Laboratory Facility and Expand B: NeoGenomics, Inc. Announces New Laboratory Facility and Expanded Product Line FORT MYERS, Fla., Feb 10, 2004 /PRNewswire-FirstCall via COMTEX/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) today announced the opening of a new expanded laboratory facility in Ft. Myers, Florida as well as several new test offerings. The new 5,200-square-foot facility has three separate environmentally controlled, clean rooms as well as an expanded main laboratory that will allow NeoGenomics to greatly scale its current operations and expand into other profitable testing niches. Thomas H. White, CEO, said, "This new lab will allow us to increase our output while maintaining our industry-leading 3-day turnaround times for oncology cytogenetics testing. More importantly, however, the new facility allows us to extend our current product line into several new areas such as additional perinatology testing and flow cytometry testing. By expanding our product line, we believe that we will be able to better service our clients as well as increase our average revenue per case." Whether they are interested in the clinical testing provided by NeoGenomics or participating in a research project, regional oncologists and physicians stand to gain with the opening of the new lab. "Physicians and hospitals will all benefit from a lab of this quality in their immediate area," said Michael T. Dent, a Naples-based Obstetrician/Gynecologist and Chairman of NeoGenomics. "Neogenomics has consistently provided superior turnaround times for clinical testing, and our new facility will allow the company to increase its services and client base as we continue to grow." The new lab is located off of Interstate I-75 approximately one mile from the Southwest Florida International Airport in the Westlinks Business Park. The new address is 12701 Commonwealth Drive, Suite 9, Fort Myers, FL 33913. About NeoGenomics, Inc. NeoGenomics, Inc. has established a state-of-the-art genetic/diagnostic or "Genostics" laboratory in Ft. Myers, FL. The Company's principle operations include providing cytogenetic and molecular biology diagnostic testing services to the oncology and perinatology sectors of the healthcare industry. The Company also conducts research activities for the early diagnosis of women's diseases, such as ovarian cancer, as well as diseases in prenates and infants. For additional information on NeoGenomics, please visit our web site at www.neogenomics.org. Certain statements included in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from such statements expressed or implied herein. Factors that might cause such a difference include, among others, the company's ability to continue gaining new customers, offer new types of tests, and otherwise implement its business plan. As a result, this press release should be read in conjunction with the company's periodic filings with the SEC. SOURCE NeoGenomics, Inc. CONTACT: Mr. Steven C. Jones, NeoGenomics, Inc., +1-239-768-0600, or sjones@neogenomics.org URL: neogenomics.org prnewswire.com Copyright (C) 2004 PR Newswire. All rights reserved. -0- KEYWORD: Florida INDUSTRY KEYWORD: BIO HEA OTC MTC SUBJECT CODE: PDT * end of story *